Barriers to Accessing Internationally Controlled Essential Medicines in Uganda: A Qualitative Study

Gaby Isabelle Ooms, Paul Klatser, Hendrika A. van den Ham, Tim Reed

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Context: Access to internationally controlled essential medicines is a problem worldwide. More than five billion people cannot access opioids for pain and palliative care or do not have access to surgical care or anesthetics, 25 million people living with epilepsy do not have access to their medicines, and 120,000 women die annually owing to postpartum hemorrhage. In Uganda, access to controlled medicines is also problematic, but a lack of data on factors that influence access exists. Objectives: The objective of this study was to identify the social, cultural, and regulatory barriers that influence access to internationally controlled essential medicines in Uganda. Methods: Semistructured interviews with 15 key stakeholders with knowledge on controlled medicines from relevant institutions in Uganda. Interviews were transcribed verbatim and analyzed using the Access to Medicines from a Health System Perspective framework. Results: Barriers in accessing controlled medicines were experienced owing to lack of prioritization, difficulties in finding the balance between access and control, deficiencies in the workings of the estimate and distribution system, lack of knowledge, inadequate human resources, expenses related to use and access, and stigma. It was believed that some abuse of specific controlled medicines occurred. Conclusion: The findings of this research indicate that to improve access to internationally controlled essential medicines in Uganda, health system strengthening is needed on multiple fronts. Active engagement and concerted efforts are needed from all stakeholders to ensure access and prevent abuse.

Original languageEnglish
Pages (from-to)835-843.e1
Number of pages10
JournalJournal of Pain and Symptom Management
Volume58
Issue number5
Early online date11 Jul 2019
DOIs
Publication statusPublished - 1 Nov 2019

Fingerprint

Uganda
Interviews
Postpartum Hemorrhage
Health
Palliative Care
Opioid Analgesics
Anesthetics
Epilepsy
Pain
Research

Keywords

  • access to medicines
  • Controlled medicines
  • drug control
  • essential medicines
  • opioid analgesics
  • psychotropic substances

Cite this

Ooms, Gaby Isabelle ; Klatser, Paul ; van den Ham, Hendrika A. ; Reed, Tim. / Barriers to Accessing Internationally Controlled Essential Medicines in Uganda : A Qualitative Study. In: Journal of Pain and Symptom Management. 2019 ; Vol. 58, No. 5. pp. 835-843.e1.
@article{01d641ec8fb64c11b13c66b697d12158,
title = "Barriers to Accessing Internationally Controlled Essential Medicines in Uganda: A Qualitative Study",
abstract = "Context: Access to internationally controlled essential medicines is a problem worldwide. More than five billion people cannot access opioids for pain and palliative care or do not have access to surgical care or anesthetics, 25 million people living with epilepsy do not have access to their medicines, and 120,000 women die annually owing to postpartum hemorrhage. In Uganda, access to controlled medicines is also problematic, but a lack of data on factors that influence access exists. Objectives: The objective of this study was to identify the social, cultural, and regulatory barriers that influence access to internationally controlled essential medicines in Uganda. Methods: Semistructured interviews with 15 key stakeholders with knowledge on controlled medicines from relevant institutions in Uganda. Interviews were transcribed verbatim and analyzed using the Access to Medicines from a Health System Perspective framework. Results: Barriers in accessing controlled medicines were experienced owing to lack of prioritization, difficulties in finding the balance between access and control, deficiencies in the workings of the estimate and distribution system, lack of knowledge, inadequate human resources, expenses related to use and access, and stigma. It was believed that some abuse of specific controlled medicines occurred. Conclusion: The findings of this research indicate that to improve access to internationally controlled essential medicines in Uganda, health system strengthening is needed on multiple fronts. Active engagement and concerted efforts are needed from all stakeholders to ensure access and prevent abuse.",
keywords = "access to medicines, Controlled medicines, drug control, essential medicines, opioid analgesics, psychotropic substances",
author = "Ooms, {Gaby Isabelle} and Paul Klatser and {van den Ham}, {Hendrika A.} and Tim Reed",
year = "2019",
month = "11",
day = "1",
doi = "10.1016/j.jpainsymman.2019.07.002",
language = "English",
volume = "58",
pages = "835--843.e1",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "5",

}

Barriers to Accessing Internationally Controlled Essential Medicines in Uganda : A Qualitative Study. / Ooms, Gaby Isabelle; Klatser, Paul; van den Ham, Hendrika A.; Reed, Tim.

In: Journal of Pain and Symptom Management, Vol. 58, No. 5, 01.11.2019, p. 835-843.e1.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Barriers to Accessing Internationally Controlled Essential Medicines in Uganda

T2 - A Qualitative Study

AU - Ooms, Gaby Isabelle

AU - Klatser, Paul

AU - van den Ham, Hendrika A.

AU - Reed, Tim

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Context: Access to internationally controlled essential medicines is a problem worldwide. More than five billion people cannot access opioids for pain and palliative care or do not have access to surgical care or anesthetics, 25 million people living with epilepsy do not have access to their medicines, and 120,000 women die annually owing to postpartum hemorrhage. In Uganda, access to controlled medicines is also problematic, but a lack of data on factors that influence access exists. Objectives: The objective of this study was to identify the social, cultural, and regulatory barriers that influence access to internationally controlled essential medicines in Uganda. Methods: Semistructured interviews with 15 key stakeholders with knowledge on controlled medicines from relevant institutions in Uganda. Interviews were transcribed verbatim and analyzed using the Access to Medicines from a Health System Perspective framework. Results: Barriers in accessing controlled medicines were experienced owing to lack of prioritization, difficulties in finding the balance between access and control, deficiencies in the workings of the estimate and distribution system, lack of knowledge, inadequate human resources, expenses related to use and access, and stigma. It was believed that some abuse of specific controlled medicines occurred. Conclusion: The findings of this research indicate that to improve access to internationally controlled essential medicines in Uganda, health system strengthening is needed on multiple fronts. Active engagement and concerted efforts are needed from all stakeholders to ensure access and prevent abuse.

AB - Context: Access to internationally controlled essential medicines is a problem worldwide. More than five billion people cannot access opioids for pain and palliative care or do not have access to surgical care or anesthetics, 25 million people living with epilepsy do not have access to their medicines, and 120,000 women die annually owing to postpartum hemorrhage. In Uganda, access to controlled medicines is also problematic, but a lack of data on factors that influence access exists. Objectives: The objective of this study was to identify the social, cultural, and regulatory barriers that influence access to internationally controlled essential medicines in Uganda. Methods: Semistructured interviews with 15 key stakeholders with knowledge on controlled medicines from relevant institutions in Uganda. Interviews were transcribed verbatim and analyzed using the Access to Medicines from a Health System Perspective framework. Results: Barriers in accessing controlled medicines were experienced owing to lack of prioritization, difficulties in finding the balance between access and control, deficiencies in the workings of the estimate and distribution system, lack of knowledge, inadequate human resources, expenses related to use and access, and stigma. It was believed that some abuse of specific controlled medicines occurred. Conclusion: The findings of this research indicate that to improve access to internationally controlled essential medicines in Uganda, health system strengthening is needed on multiple fronts. Active engagement and concerted efforts are needed from all stakeholders to ensure access and prevent abuse.

KW - access to medicines

KW - Controlled medicines

KW - drug control

KW - essential medicines

KW - opioid analgesics

KW - psychotropic substances

UR - http://www.scopus.com/inward/record.url?scp=85073884038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073884038&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2019.07.002

DO - 10.1016/j.jpainsymman.2019.07.002

M3 - Article

VL - 58

SP - 835-843.e1

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 5

ER -